Alzheimer’s disease and aducanumab. What now?

Neurology/Neurosurgery Grand Rounds

Friday, November 12, 2021 at 8:00 AM


Grand Round starts in:

Online Streaming
November 12th, 2021
1.00 AMA PRA Category 1 Credit Hours

Description

Alzheimer’s disease and aducanumab. What now?

Dates and Times

Start: 11/12/2021 8:00 AM
End: 11/12/2021 9:00 AM

Objectives

  • Explain the need for cognitive impairment screens in the context of new disease modifying therapies.
  • Describe patient eligibility, medical infrastructure and workflow requirements for delivering disease modifying therapies.

Speakers

  • Dr. Chad Hales
    • Alzheimer’s disease and aducanumab. What now?

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222